Convergence of case-specific epigenetic alterations identify a confluence of genetic vulnerabilities tied to opioid dependence
Olivia CorradiniD, Richard C. SallariiD, An T. Hoang, Bibi S. Kassim, Gabriella Ben Hutta, Lizette Cuoto, Bryan C. QuachiD, Katreya LovrenertiD, Cameron Hays, Berkley E. GryderiD, Marina IskhakovaiD, Hannah M. CatesiD, Yanwei SongiD, Cynthia F. BartelsiD, Dana B. HancockiD, Deborah C. MashiD, Eric Otto JohnsoniD, Schahram AkbarianiD, Peter C. ScacheriiD
Abstract
Opioid dependence is a highly heterogeneous disease driven by a variety of genetic and environmental risk factors which have yet to be fully elucidated. We interrogated the effects of opioid dependence on the brain using ChIP-seq to quantify patterns of H3K27 acetylation in dorsolateral prefrontal cortical neurons isolated from 51 opioid-overdose cases and 51 accidental death controls. Among opioid cases, we observed global hypoacetylation and identified 388 putative enhancers consistently depleted for H3K27ac. Machine learning on H3K27ac patterns predicts case-control status with high accuracy. We focus on case-specific regulatory alterations, revealing 81,399 hypoacetylation events, uncovering vast inter-patient heterogeneity. We developed a strategy to decode this heterogeneity based on convergence analysis, which leveraged promoter-capture Hi-C to identify five genes over-burdened by alterations in their regulatory network or "plexus": ASTN2, KCNMA1, DUSP4, GABBR2, ENOX1. These convergent loci are enriched for opioid use disorder risk genes and heritability for generalized anxiety, number of sexual partners, and years of education. Overall, our multi-pronged approach uncovers neurobiological aspects of opioid dependence and captures genetic and environmental factors perpetuating the opioid epidemic.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 2
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Heterogeneous epigenetic variation converges on splicing dysregulation in opioid addiction
Fatir A. Qureshi, Chesna Apere, … Olivia Corradin·medRxiv·Dec 29, 2025
- Transcriptional alterations in opioid use disorder reveal an interplay between neuroinflammation and synaptic remodeling
Marianne L. Seney, Sam-Moon Kim, … Ryan Wellington Logan·Biological PsychiatryPeer-reviewed·Jun 12, 2021
- Leveraging genome-wide data to investigate differences between opioid use vs. opioid dependence in 41,176 individuals from the Psychiatric Genomics Consortium
Renato A Polimanti, Raymond Kenney Walters, … Joel E. Gelernter·Molecular PsychiatryPeer-reviewed·Feb 25, 2020
- Genome-wide analyses reveal novel opioid use disorder loci and genetic overlap with schizophrenia, bipolar disorder, and major depression.
Børge Holen, Alexey A. Shadrin, … Ole A. Andreassen·Addiction BiologyPeer-reviewed·Apr 28, 2023
- Epigenome-wide study of brain DNA methylation among opioid users and controls
Chang Shu, David W. Sosnowski, … Brion S. Maher·bioRxiv·Nov 10, 2020
- Sex-divergent brain epigenetic reprogramming by chronic opioids
Camille Falconnier, Alba Caparros-Roissard, … Pierre-Éric Lutz·bioRxiv·Oct 27, 2025